MGRX logo

Mangoceuticals, Inc. Stock Price

NasdaqCM:MGRX Community·US$15.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MGRX Share Price Performance

US$1.12
-1.50 (-57.25%)
US$1.12
-1.50 (-57.25%)
Price US$1.12

MGRX Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with imperfect balance sheet.

6 Risks
0 Rewards

Mangoceuticals, Inc. Key Details

US$466.9k

Revenue

US$183.9k

Cost of Revenue

US$283.0k

Gross Profit

US$21.9m

Other Expenses

-US$21.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.55
60.61%
-4,621.05%
0.6%
View Full Analysis

About MGRX

Founded
2021
Employees
3
CEO
Jacob Cohen
WebsiteView website
www.mangoceuticals.com

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Recent MGRX News & Updates

Recent updates

No updates